ACHE and Alzheimer disease: In this work we describe the synthesis and biological evaluation of all these compounds designed as MSM for AD therapy, an effort that has allowed us to identify compound QN8 (Figure 2) as a potent, selective and non-competitive human recombinant acetylcholinesterase (hrAChE) inhibitor.